Remedy, the renowned developer behind critically acclaimed titles like Alan Wake, Control, and Max Payne, has released its latest financial results, offering a mixed bag of outcomes. Despite the commercial flop of FBC: Firebreak, a multiplayer spin-off of Control, the studio's Q1 revenue of €13.1 million represents only a 1.9% decrease from the previous year. However, operating profits took a more significant hit, down 23% to €1 million, largely attributed to the €16.4 million loss incurred by Firebreak.
The relatively stable revenue can be attributed to increased game sales and royalties, particularly from the launch of Alan Wake 1 and 2 on Amazon Luna, and the continued strong performance of Control, which sees year-over-year sales growth. Moreover, the upcoming Control Resonant, slated for a 2026 release and now fully owned by Remedy after a €17 million purchase of rights from 505 Games, is positioned as a key priority for reversing the studio's fortunes.
CEO's Outlook and Studio Efficiency
"Remedy has a pivotal year ahead, and we are off to a good start," stated CEO Jean-Charles Gaudechon, reflecting on the financial results and the studio's forthcoming projects. "Our first quarter was profitable, our games on the market performed to our expectations, and we're making steady progress with our development projects. Delivering a high-quality Control Resonant with a successful launch is our top priority, and we are on track for our 2026 launch."
Jean-Charles Gaudechon, CEO of Remedy
"We have a studio with world-class talent and a track record in delivering multi-award-winning titles at structurally more efficient budgets compared to many of our peers. The studio is the right size for the ambitions ahead of us, and our focus now is on execution."
Jean-Charles Gaudechon, CEO of Remedy
Lessons from Firebreak and Future Prospects
Although FBC: Firebreak did not achieve commercial success, its impact on Remedy's overall financial health was mitigated by its smaller, more controlled investment. This contrasts with the broader industry trend of high-risk, high-reward live-service projects. The game will remain playable, as maintaining its infrastructure is not expected to incur significant costs, according to the developer.
The focus has squarely shifted to Control Resonant, with high expectations for a quicker path to profitability compared to Alan Wake 2, which required over a year and 2 million sales to become profitable, partly due to its deal with Epic Games. The self-published nature of Control Resonant, coupled with Remedy's full ownership, suggests a potentially more lucrative outcome.
Financial Highlights and Strategic Moves
| Metric | Value |
|---|---|
| Q1 Revenue: | €13.1 million (down 1.9%) |
| Q1 Operating Profit: | €1 million (down 23%) |
| FBC: Firebreak Loss: | €16.4 million |
| Alan Wake 1 & 2 Launch Platform: | Amazon Luna |
| Control Resonant Launch: | 2026 |
| Rights Purchase for Control: | €17 million from 505 Games |
| Alan Wake 2 Profitability Milestone: | Over 1 year, 2 million sales |
Remedy's strategy for recovery and growth hinges on the success of Control Resonant and the continued performance of its existing IPs. With a focus on efficient budgeting and a return to its single-player, narrative-driven roots with Control Resonant, the studio aims to navigate the challenges posed by Firebreak's flop and position itself for a stronger financial standing in the upcoming year.
The upcoming launch of Control Resonant will be closely watched, not just for its commercial performance but also as a testament to Remedy's ability to execute on its vision with "structurally more efficient budgets." If successful, it could mark a turning point for the studio, solidifying its place among peers while avoiding the pitfalls of risky, large-scale live-service ventures.